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Introduction
 A Consensus Statement in 1990 from the United States 
National Institutes of Health indicated that equivalent 
survivals occur from early breast cancer irrespective 
of whether treatment is by mastectomy or breast 
conserving surgery and radiotherapy (U.S. Dept. Health 
and Human Services and National Institutes of Health, 
1990). Australian clinical practice guidelines for the 
management of early breast cancer, released in 1995 and 
2001, were consistent with this Statement and indicated 
the importance of providing women a choice between 
breast conserving surgery and mastectomy (National 
Breast Cancer Centre, 2001).
 Following the U.S. Statement and reviews of evidence 
from randomized trials (Abrams et al., 1995; Fisher et al., 
1995), mastectomy rates declined markedly in the U.S. 
(Lazovich et al., 1991; Lazovich et al., 1997; Habermann 
et al., 2010), Canada, (Gaudette et al., 2004) and some 
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Abstract
 Background: The National Breast Cancer Audit Database of the Society of Breast Surgeons of Australia and 
New Zealand is used by surgeons to monitor treatment quality and for research. About 60% of early invasive 
female breast cancers in Australia are recorded. The objectives of this study are: (1) to investigate associations 
of socio-demographic, health-system and clinical characteristics with treatment of invasive female breast cancer 
by mastectomy compared with breast conserving surgery; and (2) to consider service delivery implications. 
Materials and Methods: Bi-variable and multivariable analyses of associations of characteristics with surgery 
type for cancers diagnosed in 1998-2010. Results: Of 30,299 invasive cases analysed, 11,729 (39%) were treated by 
mastectomy as opposed to breast conserving surgery. This proportion did not vary by diagnostic year (p>0.200). 
With major city residence as the reference category, the relative rate (95% confidence limits) of mastectomy 
was 1.03 (0.99, 1.07) for women from inner regional areas and 1.05 (1.01, 1.10) for those from more remote 
areas. Low annual surgeon case load (≤10) was predictive of mastectomy, with a relative rate of 1.08 (1.03, 1.14) 
when compared with higher case loads. Tumour size was also predictive, with a relative rate of 1.05 (1.01, 1.10) 
for large cancers (40+ mm) compared with smaller cancers (<30 mm). These associations were confirmed in 
multiple logistic regression analysis. Conclusions: Results confirm previous studies showing higher mastectomy 
rates for residents of more remote areas, those treated by surgeons with low case loads, and those with large 
cancers. Reasons require further study, including possible effects of surgeon and woman’s choice and access to 
radiotherapy services. 
Keywords: Mastectomy - socio-demographic - clinical determinants 
RESEARCH ARTICLE
Factors Predictive of Treatment by Australian Breast Surgeons 
of Invasive Female Breast Cancer by Mastectomy rather than 
Breast Conserving Surgery
David Roder1,2*, Helen Zorbas1, James Kollias3, Chris Pyke3, David Walters3, 
Ian Campbell3, Corey Taylor3, Fleur Webster1
European countries, (Zorzi et al., 2006), although with 
a more recent upturn suggested in some North American 
localities (Tuttle et al., 2007; Katipamula et al., 2009; 
Dragun et al., 2012a; 2012b). Australian data also showed 
a trend away from mastectomy towards breast conserving 
surgery both nationally and in a number of jurisdictions 
(Hill et al., 1990; 1994; 1999; Byrne et al., 1993; South 
Australian Cancer Registry, 2000; Cuncins-Hearn et al., 
2006; Kricker, 2011). Today only about 40% of early 
breast cancers are treated by mastectomy in the U.S. and 
Australia (Cuncins-Hearn et al., 2006; Habermann et al., 
2010). 
 Mastectomy rates for early invasive disease vary 
widely within and between countries (Hill et al., 1990; 
1994; 1999; Lazovich et al., 1991; Byrne et al., 1993; 
Taylor et al., 1999; South Australian Cancer Registry, 
2000; Federation European Cancer Societies, 2004; 
Anderson et al., 2008; Dixon and Mak, 2008; Kricker, 
2011; Dragun et al., 2012a), with higher rates reported for 
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Central and Eastern Europe, and low resource countries 
(Federation European Cancer Societies, 2004; Anderson 
et al., 2008). Studies in Australia and North America 
have reported higher rates in residents of more remote 
rural settings than city locations, in women treated by 
surgeons with low case loads, and for larger and more 
advanced breast cancers (Lazovich et al., 1991; Taylor et 
al., 1999; Dragun et al., 2012a; 2012b). In North America, 
private health insurance has been linked to greater use of 
breast conserving surgery (Lazovich et al., 1991; Dragun 
et al., 2012a; 2012b). In general, breast cancers detected 
through mammography screening in Australia have had 
lower mastectomy rates (Samnakay et al., 2005; Cancer 
Australia, 2012; Roder et al., 2012) with rates of around 
28% applying in 1996-2005 and with lower rates applying 
to cancers detected at subsequent than initial screening 
rounds (Cancer Australia, 2012; Roder et al., 2012).
 Data from BreastScreen Australia have indicated that 
screen-detected invasive cancers are more likely to be 
treated by mastectomy in women from non-metropolitan 
than metropolitan areas, especially in women from outer 
regional and more remote locations (Cancer Australia, 
2012). Aboriginal and Torres Strait Islander women have 
had much higher mastectomy rates than other women, 
as have women from the third and fourth lowest socio-
economic quintiles (Kotwall et al., 1998; Cancer Australia, 
2012). Other studies have shown higher mastectomy rates 
for women from lower than higher socio-economic areas 
(Taylor et al., 1999; Cancer Australia, 2012; Roder et al., 
2012). A secular decrease in mastectomy rates was evident 
for screened women between 1996 and 2005 (Cancer 
Australia, 2012; Roder et al., 2012). 
	 Many	factors	influence	choice	of	surgery	type	apart	
from socio-demographic and tumour characteristics. Some 
studies have pointed to surgeon choice as a key determinant 
whereas others have emphasized the importance of the 
woman’s choice (Kotwall et al., 1998; Dixon and Mak, 
2008; Caldon et al., 2011). North American data indicate 
that surgeons trained prior to the 1980s are more likely to 
use mastectomy (Kotwall et al., 1998). North American 
data have also indicated that female surgeons are more 
likely to perform breast conserving surgery (Mandelblatt 
et al., 2001). Additional evidence suggests that many 
women, if given information on these procedures and time 
to consider the options, will select mastectomy (Caldon et 
al., 2011). Another factor affecting choice may be access 
to radiotherapy services, which would be lower in many 
remote areas and may predispose to higher mastectomy 
rates to avoid breast conserving surgery where adjuvant 
radiotherapy is strongly advised (U.S. Dept. Health and 
Human Services, 1990; National Breast Cancer Centre, 
2001). Other considerations may include fear of recurrence 
in the absence of a mastectomy or fear of the side effects 
of radiotherapy if choosing breast conserving surgery. 
In addition, access to breast reconstruction may be 
considered by women in relation to surgical options.
 In this study we investigate mastectomy rates among 
women treated by Australian breast surgeons participating 
in the National Breast Cancer Audit (Roder et al., 2010). 
Although early breast cancers treated by these surgeons 
were not selected to be representative of all early breast 
cancers in Australia, they comprise the majority and 
appear to be broadly representative in that their survivals 
are similar (Roder et al., 2010). Furthermore differences in 
survival from these cancers by conventional risk factors, 
such as tumour size, grade, nodal status and oestrogen 
receptor status, accord with differences observed in 
population-based studies, indicating that these data may 
be a credible basis for population-wide inferences (Roder 
et al., 2010). 
 Mastectomy rates are investigated by socio-
demographic and cancer characteristics. In particular, 
associations of mastectomy rates with surgeon case load 
and remoteness of residence are investigated following 
international and regional evidence from Australia 
indicating the importance of these features as determinants 
of mastectomy (Lazovich et al., 1991; Taylor, et al., 
1999; Cancer Australia, 2012; Dragun et al., 2012a). 
Implications of results for health-system improvement 
are considered. Ethics approval for this study was 
obtained from the research ethics committee of the Royal 




 Approximately 95,700 early invasive breast cancers 
were diagnosed in Australia between 1998 and 2010 
(Australian Institute of Health and Welfare, 2008; 
Australian Institute of Health and Welfare, Cancer 
Australia and Australasian Association of Cancer 
Registries, 2012; Cancer Institute NSW, 2012). The 
proportion recorded on the National Breast Cancer 
Database has increased progressively and represents about 
60% of cases (Roder et al., 2010).  The National Breast 
Cancer Audit did not include residential postcode in its 
minimum data set throughout the study period. In this 
study we analysed data for 30,299 early invasive breast 
cancers diagnosed in Australian women and treated by 
mastectomy or complete local excision where residential 
postcode was recorded (Roder et al., 2010).
Data collection
 Variables analysed as candidate predictors of 
mastectomy included all person, provider and cancer 
descriptors recorded on the Database. This followed other 
studies that indicated the potential contribution of a wide 
range of person, provider and cancer characteristics to 
choosing mastectomy (Lazovich et al., 1997; Taylor et 
al., 1999; Zorzi et al., 2006; Dragun et al., 2012a; 2012b). 
Variables analysed included: 1) Age at diagnosis (<30, 
30-39, 40-49, 50-59, 60-69, 70-79, 80+ years). 2) Place 
of residence (major city, inner regional, outer regional, 
and remote) (Australian Institute of Health and Welfare, 
Cancer Australia and Australasian Association of Cancer 
Registries, 2008). 3) Privately health insurance (yes/no). 
4) Socio-economic quintile (SEIFA Index of Relative 
Index of Socioeconomic Disadvantage, inferred from 
residential postcode) (Australian Bureau of Statistics, 
1998). 5) Location of treatment centre (major city, inner 
regional, more remote) (Australian Institute of Health and 
Welfare, Cancer Australia and Australasian Association of 
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Cancer Registries, 2008). 6) Surgeon mean annual case 
load	(≤10,	11-30,	31-100,	101+).	7)	Year	of	diagnosis.	8)	
Referral source (symptomatic, non-symptomatic from 
BreastScreen, non-symptomatic from other source). 9) 
Breast cancer size (<10, 10-14, 15-19, 20-29, 30-39, 40+ 
mm); histology type (ductal, lobular, other), grade (low, 
intermediate, high), lymphatic/vascular invasion (positive/
negative), nodal involvement (positive/negative), 
oestrogen and progesterone receptor status (positive/
negative), HER-2 receptor status (positive/negative), and 
number of tumour foci (1, 2, 3+). 
Data analysis
 Initially bi-variable associations of these variables 
with mastectomy (as opposed to breast conserving 
surgery) were investigated using the Pearson chi-square 
test for binary and nominal variables and the Mann-
Whitney U test and Kruskal-Wallis ANOVA for ordinal 
variables (Armitage and Berry, 1987; StataCorp, 2005). 
Relative rates (i.e., rate ratios) for mastectomy were 
analysed by variable category. Bi-variable analyses 
were also undertaken of these variables with case load 
and residential location to gain a better understanding 
of factors associated with these characteristics. Finally 
multiple logistic regression analyses were undertaken to 
determine key predictors of mastectomy, checking that 
model assumptions such as lack of co-linearity were met 
(Armitage and Berry, 1987; StataCorp, 2005).
Results 
 The proportion of cases treated by mastectomy as 
opposed to complete local excision was 38.7%, which did 
not	vary	to	a	statically	significant	extent	across	the	1998-
2010 diagnostic period (p>0.200). Results of bi-variable 
and multi-variable analyses were as follows:
A. Bi-variable: Mastectomy versus breast conserving 
surgery
 Residential location: Associations were evident 
with mastectomy (p=0.045 and p=0.014 for location as 
a nominal and ordinal variable respectively). Relative 
rates	 (95%	confidence	 limits)	of	mastectomy	 indicated	
small elevations for inner regional and more remote 
areas respectively of 1.03 (0.99, 1.07) and 1.05 (1.01, 
1.10) when major city location was used as the reference 
category (Table 1). Outer regional, remote and very 
remote areas were combined in this analysis due to small 
numbers	and	because	statistically	significant	differences	
were not evident in mastectomy rates between these areas 
(p=0.081 and p=0.218 for area treated as a nominal and 
ordinal variable respectively).
 Case load: An association was evident with mastectomy 
(p=0.002 for case load as a nominal variable). No 
significant	difference	was	evident,	however,	between	case	
load categories of 11-30, 31-100 and 101+ (p=0.707 and 
p=0.405 for case load as a nominal and ordinal variable 
respectively). When these categories were combined, the 
relative rate of mastectomy between the lowest case load 
category	(≤10)	and	higher	case	loads	(11-101+)	was	1.08	
(1.03, 1.14) (Table 1).
 Tumour size: Tumour size was associated with 
mastectomy (p=0.033 for size as a nominal variable). 
No difference in mastectomy rates was evident between 
sizes in the range below 30mm (p=0.460 and p=0.570 
for size as nominal and ordinal variables respectively). 
When larger tumours of 30+ mm were compared with 
smaller categories, the relative rate of mastectomy was 
not elevated for the 30-39mm category at 0.97 (0.93, 
1.02) (Table 1). When the mastectomy rate for the 
largest category (40+mm) was compared with all smaller 
categories combined, the relative rate was also 1.05 (1.01, 
1.10). 
 Lymphatic/vascular invasion: A small elevation in 
rate	 of	mastectomy	of	marginal	 statistical	 significance	
(p=0.069) was observed in cases with lymphatic/vascular 
invasion, the relative rate being 1.03 (1.00, 1.07) (Table 
1).
 Other characteristics: Other characteristics not 
showing associations with mastectomy included age at 
diagnosis, socio-economic status, referral source, year 
of diagnosis, treatment centre location, private health 
insurance, histology type, histology grade, nodal status, 
oestrogen receptor status, progesterone receptor status, 
HER-2 receptor status, and number of tumour foci 
(p>0.200). 
 Case load: Further bi-variable analyses indicated a 





































































































Table 1. Relative Rates (95% confidence limits) of Mastectomy Compared with Breast Conserving Surgery 
(BCS); Australian Breast Cancer Audit, 1998-2010*
 Number of cases (%) Relative Rates P values**
 BCS                Mastectomy
Residential location:  Major city (ref.) 13,166 (61.7) 8,169 (38.3)  1 X²(2) p=0.045
 Inner regional 3,599 (60.6) 2,339 (39.4)  1.03 (0.99, 1.07)  MWp=0.014
 More remote 1,805 (59.6) 1,221 (40.4)  1.05 (1.01, 1.10)
Annual surgeon case load: > 10 (ref.) 17,111 (61.6) 10,687 (38.4)  1 X²(1) p=0.002
	 ≤	10	 1,459	(58.3)	 1,042	(41.7)		 1.08	(1.03,	1.14)
Large tumour size (mm):  < 30 (ref.) 14,022 (61.4) 8,807 (38.6)  1 X²(2) p=0.033
 30-39 1,911 (62.4)  1,152 (37.6) 0.97 (0.93, 1.02) MWp=0.222
 40+ 2,159 (59.4)  1,472 (40.6) 1.05 (1.01, 1.10)
Lymphatic/vascular invasion: Absent (ref.) 12,237 (61.5) 7,672 (38.5)  1 X²(1) p=0.069
 Present 4,518 (60.3) 2,979 (39.7)  1.03 (1.00, 1.07)
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remote residential location, more remote treatment centre 
location, not having primary health insurance, lower socio-
economic status, an earlier diagnostic year, symptomatic 
presentation, positive nodal status, negative oestrogen 
and progesterone receptor status, positive HER-2 receptor 
status, and single cancer focus as opposed to multiple foci 
(Table 2). Other variables not showing an association 
with	case	load	included	large	tumour	size	(p≥0.124)	and	
lymphatic/vascular invasion (p=0.505).
 Residential location: Further bi-variable analyses 
of associations with residential remoteness indicated a 
positive association with the remoteness of treatment 
location (p<0.001), lower socio-economic status 
(p<0.001),	 referral	 source	 (p≤0.028)	 and	 tumour	 size	
(p≤0.046)	 (Table	 3).	 By	 comparison,	 other	 variables	





































































































Table 2. Relative Rates (95% confidence limits) of Breast Cancer Cases Attending Surgeons with Low Annual 
Case Loads; Australian Breast Cancer Audit, 1998-2010*
 Case numbers Relative Rates P values**
	 (case	load	>	10)				(case	load	≤	10)
Residential location: Major city (ref.) 19,688 1,647 1 X²(1)p<0.001
 More remote 5,406 532 1.16 (1.06, 1.27) MWp<0.001
 Inner regional 2,704 322 1.38 (1.23, 1.54) 
Treatment centre location:  Major city (ref.) 21,035 836 1 X²(2)p<0.001
 Inner regional 5,384 1,256 4.95 (4.55, 5.38) MWp<0.001
 More remote 1,379 409 5.98 (5.37, 6.67) 
Private	health	insurance:		 Yes	(ref.)	 14,346	 1,070	 1	 X²(1)p<0.001
 No 9,772 1,199 1.57 (1.46, 1.70) 
SEIFA (SES) quintile:  1 {low} (ref.) 5,350 531 1 X²(2)p<0.001
 2 5,330 507 0.96 (0.86, 1.08) MWp=0.002
 3 + {mid – high} 17,118 1,463 0.87 (0.79, 0.96) 
Referral source:  Symptomatic (ref.) 15,134 1,442 1 X²(2)p<0.001
 BreastScreen 7,789 580 0.80 (0.73, 0.87) 
 Other 2,361 154 0.70 (0.60, 0.83) 
Nodal status: Negative (ref.) 15,875 1,254 1 X²(1)p<0.001
 Positive 9,552 910 1.19 (1.09, 1.29) 
Oestrogen receptor status:  Positive (ref.) 21,812 1,885 1 X²(1)p=0.001
 Negative 5,123 529 1.18 (1.07, 1.29) 
Progesterone receptor status: Positive (ref.) 18,833 1,618 1.00 X²(1)p=0.014
 Negative 8,005 770 1.11 (1.02, 1.20) 
HER-2 receptor status:  Negative (ref.) 17,081 1,496 1 X²(1)p<0.001
 Positive 3,128 343 1.23 (1.10, 1.37) 
Number of cancer foci:  1 (ref.) 16,520 1,650 1   X²(2)p=0.018
 2 1,738 137 0.80 (0.68, 0.95) MWp= 0.011
 3 + 1,979 176 0.90 (0.77, 1.04) 
Diagnostic	years:	 ≤	2001	(ref.)	 2,137	 323	 1	 X²(2)p<0.001
 2002-05 5,366 585 0.75 (0.66, 0.85) MWp<0.001
 2006 + 20,295 1,593 0.55 (0.50, 0.62) 






































































































Table 3. Relative Rates (95% confidence limits) of Breast Cancer Cases Residing Outside a Major City; Australian 
Breast Cancer Audit, 1998-2010*
 Number [%]  Relative rates P values**
 Major City Inner More Major Inner  More remote
   regional remote City regional
Treatment centre location:
 Major city (n=21,871)   15,834 (72.4) 4,149 (19.1) 1,888 (8.6) 1 1 1 X²(4) p<0.001
 Inner regional (n=6,640)  4,293 (64.7) 1,449 (21.8) 898 (13.5)  1 1.22 (1.15, 1.28)  1.62 (1.51, 1.75)
 More remote (n=1,788)  1,208 (67.6) 340 (19.0) 240 (13.4) 1 1.06 (0.96, 1.17) 1.56 (1.38, 1.76)
SEIFA (SES) quintile: 
	 1	{low}	(n=5,881)	 2,513	(42.7)		 1,795	(30.5)		1,573	(26.7)		 1	 1	 1	 Χ2(4) p<0.001
 2 (n=5,837)  3,195 (54.7) 1,873 (32.1)  769 (13.2)  1 0.89 (0.84, 0.93)  0.22 (0.21, 0.24)  KWp<0.001
 3 + {mid - high} (18,581) 15,627 (84.1) 2,270 (12.2) 684 (3.7) 1 0.30 (0.29, 0.32) 0.11 (0.10, 0.12)
Referral source: Symptomatic  (n=16,576)  11,617 (70.1)  3,247 (19.6)  1,712 (10.3)  1 1 1 X²(4) p<0.001
 BreastScreen (n=8,369)  5,808 (69.4) 1,741 (20.8) 820 (9.8) 1 1.05 (1.00, 1.09)  0.97 (0.91, 1.03) KWp=0.028
 Other (n=2,515)  1,840 (73.2) 463 (18.4) 212 (8.4) 1 0.91 (0.83, 1.00) 0.81 (0.70, 0.92) 
Large tumour size (mm):  
 <30 (n=22,829)  15,978 (70.0) 4,581 (20.1) 2,270 (9.9) 1 1 1 X²(4) p=0.005
 30-39 (n=3,063)  2,197 (71.7) 581 (19.0) 285 (9.3)  1 0.94 (0.87, 1.01)  0.92 (0.82, 1.04) KWp=0.046
 40+ (n=3,631)  2,521 (69.4)  689 (19.0) 421 (11.6) 1 0.96 (0.90, 1.03)  1.15 (1.04, 1.27)
*Invasive breast cancers treated by Australian breast surgeons (see text). ** X²(df)=Pearson chi-square (degrees of freedom); MW=Mann–Whitney U test; KW=Kruskal-
Wallis ANOVA
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location	(p≥0.106).
B. Multiple logistic regression analyses
 Three models were produced, with Model 1 including 
only those variables found in the bi-variable analyses 
to be predictive of mastectomy, and Model 2 including 
those variables plus all other person, provider and tumour 
characteristics in the Database (listed in Methods). Model 
3, which included only those variables found in the bi-
variable analyses to be predictive of mastectomy, plus 
those associated with either low case load or residential 
location, produced identical odds ratios for residential 
location and case load as Model 2 (Table 4). Model 1 and 
Model 2 gave similar results for:
 Residential location: compared with major city, the 
relative odds of mastectomy for inner regional and more 
remote areas were 1.05 (0.99, 1.11) and 1.09 (1.00, 1.17) 
respectively for Model 1 and 1.05 (0.99, 1.12) and 1.11 
(1.02, 1.20) respectively for Model 2.
 Annual surgeon case load: compared with an annual 
case load of over 10, lower case load gave relative odds 
of mastectomy of 1.14 (1.05, 1.24) and 1.15 (1.05, 1.25) 
respectively for Model 1 and Model 2.
 Large tumour size: compared with tumours under 
40mm, tumours of 40mm diameter or more gave relative 
odds of mastectomy of 1.09 (1.02, 1.17)  and 1.08 (1.00, 
1.17) respectively for Model 1 and Model 2.
 
Discussion
The results show a mastectomy rate in Australia 
from early invasive breast cancer of 39% between 1998 
and 2010, which is very similar to the 40% reported for 
1999-2004 from the same data source (Cuncins-Hearn 
et al., 2006). A similar rate of 37% was reported from 
USA SEER data for 2000-2006, although this applied 
to combined ductal carcinoma in situ and AJCC TNM 
stages I to III invasive cancers, whereas our data were for 
invasive	cancers	classified	using	the	NHMRC	definition	of	
early invasive breast cancer (i.e., tumours <50mm in size 
and	without	fixed	nodes	or	distant	metastases)	(National	
Breast Cancer Centre, 2001; Cuncins-Hearn et al., 2006; 
Habermann et al., 2010).
Results	 confirm	 international	 findings	 and	 earlier	
regional data from Australia of positive associations of 
mastectomy with remoteness of residential area (5% 
higher than for major cities) and attending low case load 
surgeons (8% higher than for higher case load surgeons) 
(Lazovich et al., 1997; Taylor et al., 1999; Dragun et al., 
2012a). Notably BreastScreen Australia data have also 
indicated higher mastectomies rates for residents of more 
remote areas (Cancer Australia, 2012). Large tumour sizes 
of 40mm or more were also predictive of mastectomy 
in the present study which is consistent with the higher 
mastectomy rates seen for larger and more advanced 
tumours in other studies (Lazovich et al., 1997; Taylor et 
al., 1999; Dragun et al., 2012b; Zorzi et al., 2006).
The reasons for higher mastectomy rates in more 
remote areas are not known. The results of this study 
indicated that women from these areas were more 
likely to be symptomatic than asymptomatic referrals, 
and to receive their treatment in inner regional or more 
remote treatment locations than other women, but these 
characteristics	were	not	selected	in	the	first	multivariable	
analysis (p>0.050) and had little effect when included in 
the second analysis. A plausible explanation may be poorer 
access to radiotherapy services in more remote areas which 
may discourage use of breast conserving surgery (note: 
adjuvant radiotherapy is strongly recommended with 
breast conserving surgery) (U.S. Dept. Health and Human 
Services and National Institutes of Health, 1990; National 
Breast Cancer Centre, 2001). The importance of surgeon 
and woman’s choice has been reported in several studies 
and	it	is	possible	that	the	influence	of	these	factors	differs	
between major cities and more remote areas (Kotwall et 
al., 1998; Mandelblatt et al., 2001; Dixon and Mak, 2008; 
Caldon et al., 2011). 
The reasons for higher mastectomy rates for women 
treated	by	surgeons	with	low	annual	case	loads	(≤10)	are	
also not known. These women tend to live in more remote 
areas and be treated in non-metropolitan centres. They 
often have no private health insurance and come from 
lower socio-economic areas. In the settings of low surgeon 
case loads, tumours were more likely to be symptomatic, 
node positive, oestrogen and progesterone receptor 
negative, and HER-2 receptor positive. Again, these 
characteristics	were	not	selected	in	the	first	multivariable	
model (p>0.05) and had little effect on the odds ratio for 
low case load when included in the second analysis. The 
possibility of surgeons with low case loads and patients 
attending them having different attitudes to surgery 
options may warrant further study (Kotwall et al., 1998; 
Mandelblatt et al., 2001; Dixon and Mak, 2008; Caldon 
et al., 2011). 
While large tumour size per se does not preclude 
effective cancer treatment by breast conserving surgery 
and radiotherapy (National Breast Cancer Centre, 2001), 
prospects for an acceptable cosmetic result may be 
reduced, particularly for large central lesions in small 
breasts when mastectomy with breast reconstruction may 
be a preferred option. Mastectomy rates were consistent 
Table 4. Relative Odds (95% confidence limits) of 
Mastectomy Compared with Breast Conserving 
Surgery; Australian Breast Cancer Audit, 1998-2010* 
Multiple Logistic Regression
 Relative odds
 Model 1**             Model 2***
Residential location: 
 Major city (n=21,335) 1 1
 Inner regional (n=5,938) 1.05 (0.99, 1.11) 1.05 (0.99, 1.12)
 More remote (n=3,026) 1.09 (1.00, 1.17) 1.11 (1.02, 1.20)
Annual surgeon case load: 
 >10 (n=27,798) 1 1
	 ≤10	(n=2,501)	 1.14	(1.05,	1.24)	 1.15	(1.05,	1.25)
Large tumour size (mm): 
 <40 (n=25,892) 1 1
	 ≥40	(n=3,631)	 1.09	(1.02,	1.17)	 1.08	(1.00,	1.17)
 Unknown (n=776) 1.00 (0.87, 1.16) 1.11 (0.93, 1.33)
*Invasive breast cancers treated by Australian breast surgeons (see text). **Model 
1 including residential location, annual case load and tumour size. ***Model 2 
including these predictors and all other socio-demographic, tumour and provider 
characteristics in the data set (see text)
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in this study by calendar year, which may indicate that 
the trend towards breast conserving surgery following 
release of the U.S. Consensus Statement and Australian 
Clinical Practice Guidelines has reached a plateau (Hill 
et al., 1990; U.S. Dept. Health and Human Services and 
National Institutes of Health, 1990; Byrne et al., 1993; Hill 
et al., 1994; 1999; South Australian Cancer Registry, 2000; 
National Breast Cancer Centre, 2001; Cuncins-Hearn et 
al., 2006; Kricker, 2011). 
Mastectomy rates did not vary by diagnostic year in the 
present study. This is in contrast to results from U.S. SEER 
data that indicate a continuing decline in mastectomy 
rates from 2000 but with the possibility of an upturn 
during 2005-2006 (Fisher et al., 1995; Tuttle et al., 2007; 
Katipamula et al., 2009; Dragun et al., 2012a; 2012b). 
This was supported by some regional and institutional 
data	from	the	U.S.	and	evidently	was	 influenced	by	an	
upturn in contra-lateral prophylactic mastectomies (Tuttle 
et al., 2007; Katipamula et al., 2009; Dragun et al., 2012a; 
2012b).
The higher mastectomy rates observed in women 
living in more remote areas and attending low case-load 
surgeons in the present study constitute relatively small 
differences. Nonetheless they warrant further investigation 
to determine whether treatment choices have been limited 
by factors such as transport and accommodation or the 
long periods that may be required away from home 
when accessing city based radiotherapy services. Other 
important considerations for women living in rural and 
remote areas considering breast conserving treatment 
include the availability of hypo fractionation techniques 
for low-risk cancers and abbreviated partial breast 
irradiation techniques (Freedman et al., 2007; 2012). 
Opportunities to increase options through access to high-
case load surgeons also need investigation.
Results indicate that the proportion of invasive 
cancers less than 30 mm in diameter that were treated 
by mastectomy was about 39%. The extent to which 
mastectomy rates might change further in response 
to additional information and by increasing access to 
radiotherapy services should be explored. It is evident 
that the majority of women with early breast cancers 
were treated by breast conserving surgery, which likely 
reflects	broad	support	of	Australian	surgeons	for	the	U.S.	
Consensus Statement, results of international collaborative 
trials that equivalent survivals occur from mastectomy 
or breast conserving surgery and radiotherapy, and the 
response of surgeons to Australian clinical practice 
guidelines for the management of early breast cancer (U.S. 
Dept. Health and Human Services and National Institutes 
of Health, 1990; National Breast Cancer Centre, 2001). 
While large tumour size of 40mm or more was predictive 
of an increased odds of mastectomy compared with breast 
conserving surgery (an increase of 8-9%), the difference 
was smaller than expected. 
In	conclusions,	our	results	confirm	previous	studies	
showing higher mastectomy rates for residents of more 
remote areas, women treated by surgeons with low case 
loads, and women with relatively large cancers. Reasons 
for these differences require further study, including 
investigation of effects of surgeon and woman’s choice 
and differences in individual access to radiotherapy 
services. 
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